The Latest Breaking News on Pharma

There's more than Eylea to like about Regeneron Pharmaceuticals right now, an analyst said Friday as REGN stock touched another record high.

There's a revolution in immunology that could completely shift a paradigm biotech stocks. And Big Pharma is paying billions to get in.

After a better-than-expected 2023, New England states will see only modest employment growth in 2024.

The need for innovative healthcare solutions, personalized medicines and treatments, and the use of advanced technologies will propel the biotech industry forward. Amid this backdrop, let’s explore the investment potential of biotech stocks TG Therapeutics (TGTX), Galapagos (GLPG), BioMarin Pharmaceutical (BMRN), and United Therapeutics (UTHR).

Bayer remains undeterred by setbacks as they forge ahead with plans to expand in the US market, showing resilience and determination in the face of challenges.

As biotech stocks boom on a strong 2024 outlook following a rough two years, the XBI ETF launches a fresh breakout.

Merck sets sail into new therapeutic waters with the 0 million acquisition of Harpoon Therapeutics, harnessing the power of innovation to navigate treat...

Revised Schedule M of Drugs and Cosmetics Rules, 1945 notified by Union Health Ministry to ensure robust quality control for pharma and biopharmaceutical products.

Get the latest on the FDA's decision to allow Florida to import medications from Canada, potentially reducing prescription costs for Americans. Learn about...

Novo Nordisk stock is Friday's IBD Stock Of The Day. Shares are in a buy zone after the firm inked deals in the weight-loss drugs space.

Thermo Fisher, an American biotech company, has halted sales of its DNA testing products in Tibet, amid concerns that its products might have assisted the Chinese government in a surveillance campaign in the ethnic region